NEW YORK (GenomeWeb News) – The plaintiff in a lawsuit that accused Sequenom of capping the price of its MaterniT21 Plus non-invasive prenatal test in order to drive up its adoption has dropped her case.

The plaintiff Bette Borenstein voluntarily dismissed her lawsuit earlier this week in US District Court for the Southern District of California five months after initiating the litigation. No reason was provided in court papers.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers describe a way to share data while keeping it secure, Agence France Presse reports.

In Science this week: genetic mutations typically associated with esophageal cancer are common in older, healthy individuals, and more.

India's Council of Scientific and Industrial Research has a new director-general, according to ScienceInsider.

A new study links more than a hundred genes to autism spectrum disorder, Discover's D-brief blog reports.